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Abstract
The unfolded protein response (UPR) is a conserved cellular response to the accumulation
of proteinaceous material in endoplasmic reticulum (ER), active both in health and disease
to alleviate cellular stress and improve protein folding. Multiple epiphyseal dysplasia
(EDM5) is a genetic skeletal condition and a classic example of an intracellular protein
aggregation disease, whereby mutant matrilin-3 forms large insoluble aggregates in the ER
lumen, resulting in a specific ‘disease signature’ of increased expression of chaperones and
foldases, and alternative splicing of the UPR effector XBP1. Matrilin-3 is expressed exclu-
sively by chondrocytes thereby making EDM5 a perfect model system to study the role of
protein aggregation in disease. In order to dissect the role of XBP1 signalling in aggrega-
tion-related conditions we crossed a p.V194D Matn3 knock-in mouse model of EDM5 with a
mouse line carrying a cartilage specific deletion of XBP1 and analysed the resulting pheno-
type. Interestingly, the growth of mice carrying the Matn3 p.V194D mutation compounded
with the cartilage specific deletion of XBP1 was severely retarded. Further phenotyping
revealed increased intracellular retention of amyloid-like aggregates of mutant matrilin-3
coupled with dramatically decreased cell proliferation and increased apoptosis, suggesting
a role of XBP1 signalling in protein accumulation and/or degradation. Transcriptomic analy-
sis of chondrocytes extracted from wild type, EDM5, Xbp1-null and compound mutant lines
revealed that the alternative splicing of Xbp1 is crucial in modulating levels of protein aggre-
gation. Moreover, through detailed transcriptomic comparison with a model of metaphyseal
chondrodysplasia type Schmid (MCDS), an UPR-related skeletal condition in which XBP1
was removed without overt consequences, we show for the first time that the differentiation-
state of cells within the cartilage growth plate influences the UPR resulting from retention of
a misfolded mutant protein and postulate that modulation of XBP1 signalling pathway pres-
ents a therapeutic target for aggregation related conditions in cells undergoing proliferation.
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Author summary
A significant proportion of genetic skeletal diseases result from misfolding of structural pro-
teins within the endoplasmic reticulum (ER) of cartilage cells (chondrocytes). Interestingly,
these diseases often share transcriptomic changes with non-skeletal conditions such as Alzhei-
mer’s disease and diabetes and include changes in the unfolded protein response (UPR). UPR
signals are conveyed through three effector molecules, IRE1, ATF6 and PERK, understanding
of which is of utmost importance for the development of novel therapeutic approaches. IRE1
is the most conserved UPR pathway, with XBP1 as its main effector. Interestingly, in our
study we show that chondrocyte response to ER stress is highly modulated by the differentia-
tion state of the cell. We have deleted the IRE1/XBP1 pathway activity in the chondrocytes of
a mouse model of multiple epiphyseal dysplasia (MED), expressing misfolding matrilin-3 pre-
dominantly in proliferating chondrocytes, and in metaphyseal chondrodysplasia type Schmid
(MCDS), resulting from mutations in type X collagen, expressed by the hypertrophic chon-
drocytes. Here, using deep phenotyping and extensive transcriptomic analysis we demonstrate
that whilst the IRE1/XBP1 pathway is redundant in hypertrophic chondrocyte pathology, it is
in fact essential for UPR responses in proliferating cells, making this highly conserved pathway
an attractive therapeutic target for a broad range of UPR related conditions.
Introduction
The unfolded protein response (UPR) is one of the canonical cellular stress pathways that is
triggered by unfolded proteins accumulating in the ER lumen. The pathway is active in both
health and disease and many secretory cells have a highly active UPR to allow a greater secre-
tory output [1]. Over the recent years, the UPR triggered by ER-stress has been recognised as a
crucial component in the pathobiology of many human diseases, including neurodegenerative
conditions, diabetes and numerous musculoskeletal phenotypes [2–6]. However, the specific
role of the UPR in the context of human disease is still being determined and it is hoped that it
will offer attractive therapeutic targets and avenues in the future.
The canonical UPR response is initiated when the chaperone protein BiP dissociates from its
three membrane bound receptors, PERK, ATF6 and IRE1 [7]. This dissociation is triggered by
the exposed hydrophobic residues of misfolded proteins in the ER lumen and the UPR then pro-
ceeds along the three signalling pathways, which are further modulated by the levels and duration
of the stress [8]. Furthermore, these branches cross talk and signal in conjunction with, or modu-
late other important mechanisms such as inflammation and autophagy, thereby offering the cell a
robust machinery to counteract protein misfolding and oxidative stress. Following dissociation of
BiP, PERK dimerises and autophosphorylates, which in turn triggers the phosphorylation of
elongation factor eIF2ɑ. This leads to attenuation of general protein translation allowing the cell
to recover from an abnormal protein load [9]. However, several proteins escape this translational
block, including ATF4, a downstream effector of PERK, which can trigger ER-stress related apo-
ptosis via CHOP (or DDIT3 [10, 11]. Following release from BiP, ATF6 translocates to the Golgi
apparatus where it is cleaved, releasing an active transcription factor. ATF6 signalling then leads
to an upregulation of chaperones and XBP1 expression, but it can also trigger apoptosis via
CHOP mediated signalling [12]. The third transmembrane sensor is IRE1, which dimerises and
autophosphorylates upon the dissociation of BiP. In the active form IRE1 can induce the alterna-
tive splicing of XBP1, producing an active transcription factor which upregulates chaperone
genes and genes responsible for ER-associated degradation of accumulated proteins (ERAD)
[13–15]. It is therefore not surprising that the XBP1 branch of the UPR pathway has been
UPR is an essential component of genetic skeletal disease
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implicated in many protein aggregation diseases including Alzheimers [16, 17], Huntington’s dis-
ease [18, 19], type II diabetes [20] and several skeletal conditions [5, 7, 12, 21] amongst others.
Multiple epiphyseal dysplasia (MED) is predominantly an autosomal dominant skeletal dys-
plasia characterised by disproportionate short-limbed dwarfism and early onset joint degenera-
tion [22]. MED results from dominant-negative mutations in three structural proteins of the
cartilage extracellular matrix (ECM); cartilage oligomeric matrix protein (COMP), matrilin-3
and type IX collagen, which interact with each other in the ECM [23]. Matrilin-3 is a tetrameric
bridging molecule that regulates collagen fibrillogenesis [24] and each monomer consists of a
single von Willebrand factor A like domain (A-domain), four EGF-like repeats and an oligomer-
isation domain. MED-causing mutations (EDM5; OMIM #607078) are located exclusively in the
disulphide bond stabilised A-domain and result in misfolding and retention of the mutant pro-
tein in the ER lumen. A classical UPR is activated with an upregulation of generic chaperones as
well as a more specific cocktail of disulphide isomerases such as CRELD2, PDIA1, PDIA3 and
PDIA6 [5]. However, the mutant protein is prone to aggregation, forming large insoluble non-
native disulphide bonded aggregates in the ER that contain a high percentage of ß-sheet folds [5,
25], suggesting a propensity to form amyloid-like deposits upon misfolding [26] that appear
resistant to degradation. This in turns leads to the dysregulation of chondrocyte apoptosis, a
decrease in chondrocyte proliferation and consequently reduced bone growth [27, 28].
We have previously demonstrated that chondrocytes from a mouse model of EDM5 with a
p.V194D mutation in Matn3 exhibited a specific upregulation of genes in the XBP1 branch of
the UPR [5, 29, 30]. A similar upregulation of XBP1 signalling was seen in the Col10a1 N617K
model of metaphyseal chondrodysplasia type Schmid (MCDS), but not in an allelic series of
pseudoachondroplasia (PSACH) causing Comp mutations, indicating gene product specificity
of this arm of the UPR [6, 31, 32]. Therefore, in order to further understand the role of XBP1
signalling in the protein aggregation and disease pathology of Matn3-related MED we crossed
a p.V194D knock-in mouse model of EDM5 with a mouse line carrying a cartilage specific
deletion of Xbp1 and analysed in-depth the resulting phenotype.
Results
Engineering the chondrocyte specific knock out of Xbp1 in the EDM5
mouse model
We have previously generated a mouse model of EDM5 (p.V194D in Matn3 and referred to as
Xbp1WT Matn3V194D in this paper, [5]). Interestingly, RT-PCR and sequencing of cDNA
derived from wild type (Xbp1WT Matn3WT) and homozygous mutant (Xbp1WT Matn3V194D)
cartilage dissected from 5-day-old mice revealed non-conventional splicing of Xbp1 in Xbp1WT
Matn3V194D chondrocytes (Fig 1A). The Xbp1WT Matn3V194D mouse line was therefore crossed
with a mouse line in which Xbp1 had been rendered inactive in chondrocytes through the
Col2a1-Cre/loxP-mediated deletion of exon 2 (Xbp1Col2CreΔex2, [21, 31]), in order to study
the role of XBP1 signalling in EDM5. This breeding strategy generated the Xbp1Col2CreΔex2
Matn3V194D mouse line. Xbp1Col2CreΔex2 Matn3V194D mice were viable and fertile; however,
mice homozygous for both mutant alleles had breeding and survival complications due to their
dramatically reduced size, breathing difficulties and narrower birth canals.
The loss of XBP1 from cartilage leads to an exacerbation of the EDM5
phenotype
Bone measurements were used to determine the effect of XBP1 deletion on endochondral
(tibia and femur lengths) and intramembranous (inner canthal distance) ossification of the
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Xbp1WT Matn3V194D mouse model. The Xbp1Col2CreΔex2 mice were slightly shorter than their
wild type littermates, as previously reported, indicating a role for Xbp1 in normal skeletal
development [21]. Xbp1WT Matn3V194D mice were shorter than both wild type mice and
Fig 1. (A) Mutation in MATN3 induced an UPR response and alternative splicing of Xbp1. (B) Xbp1Col2CreΔex2 mice presented with a mild
chondrodysplasia and were shorter than their wild type littermates. Xbp1WTMatn3V194D mice presented with typical EDM5 short limbed dwarfism. The
skeletal phenotype of Xbp1Col2CreΔex2 Matn3V194D was very severe, with short limbs, constricted ribcages and a pronounced hip dysplasia. (C) Bone
measurements using Xray analysis at 3, 6 and 9 weeks of age show disruption of endochondral ossification (tibia, femur), but not the intramembranous
ossification (inner canthal distance, ICD) in the Xbp1Col2CreΔex2, Xbp1WT Matn3V194D and Xbp1Col2CreΔex2 Matn3V194D mice (n�5, Student t-test). Key:
Xbp1u - unspliced Xbp1, Xbp1s –spliced Xbp1, ��� P<0.001.
https://doi.org/10.1371/journal.pgen.1008215.g001
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Xbp1Col2CreΔex2 mice with a comparable genetic background [33]. Unsurprisingly, the
Xbp1Col2CreΔex2 Matn3V194D mice had a more pronounced short-limbed dwarfism than that
previously reported for the Xbp1WT Matn3V194D mice, signifying a crucial protective role of
the XBP1 branch of UPR in EDM5 pathology (Fig 1B and 1C). Paradoxically, this is in direct
contrast to the minor role for XBP1 signalling proposed in the recent study of the Col10aN617K
model of metaphyseal chondrodysplasia type Schmid (MCDS) [31].
The Xbp1Col2CreΔex2 Matn3V194D mice had dramatically shorter long bones (>30% reduc-
tion compared to wild type mice and ~20% reduction compared to the Xbp1WT Matn3V194D
mice) and abnormal bell-shaped rib cages, which appeared to hinder their ability to breathe
correctly. The inner canthal distance (ICD) was not altered in any of the mice studied indicat-
ing that intramembranous ossification was not affected. Over time there was severe truncation
and rotation of the limb, abnormal bending of the long bones and severe constriction of the
rib cages in Xbp1Col2CreΔex2 Matn3V194D mice (S1 Fig).
Ablation of XBP1 dramatically altered Matn3V194D cartilage growth plate
morphology
Deletion of XBP1 in the Xbp1WT Matn3V194D mouse line severely affected the morphology of
the cartilage growth plates (Fig 2). Briefly, the Xbp1WT and Xbp1Col2CreΔex2 growth plates pre-
sented with a typical and well-organised columnar arrangement of chondrocytes in the prolif-
erative zone and an ordered progression from the resting to proliferative to hypertrophic cells
along the vertical axis of the growth plate. The growth plates from Xbp1Col2CreΔex2 mice had a
slightly reduced hypertrophic zone and small areas of hypocellularity, consistent with the pre-
viously published study [21]. In contrast, growth plates from Matn3V194D mice were character-
ised by enlarged cells in the resting and proliferative zones due to retention of misfolded
mutant matrilin-3 as previously described [33]. Finally, the growth plates from Xbp1Col2CreΔex2
Matn3V194D mice had a dramatically altered morphology with abnormally enlarged cells pres-
ent throughout the entire growth plate and concurrent with an apparent increase in the reten-
tion of mutant matrilin-3. This increased retention of mutant matrilin-3 appeared to correlate
with an increase in amyloid-like intracellular deposits detected by Congo Red fluorescence (S2
Fig). The severe disorganisation of the growth plates from the Xbp1Col2CreΔex2 Matn3V194D
mice rendered impractical any measurement of the respective zones using histology images.
However, the distribution of type X collagen (a marker of chondrocyte hypertrophy) in the
Xbp1Col2CreΔex2 Matn3V194D growth plates at 3 weeks was altered and collagen X staining
extended into the proliferative zone, coinciding with the abnormally enlarged chondrocytes
and indicating accelerated differentiation. In contrast, staining for type II collagen (a major
component of the cartilage ECM) was unaffected (Fig 2).
Chondrocyte apoptosis and proliferation are affected by the deletion of
XBP1 in Matn3V194D mice
Chondrocyte proliferation in the growth plates of both Xbp1WT Matn3V194D and Xbp1Col2-
CreΔex2 mice was significantly reduced when compared to wild type controls as previously
reported (~16% and ~40% decrease respectively) [21, 33]. By comparison, chondrocyte prolif-
eration in Xbp1Col2CreΔex2 Matn3V194D mice was decreased by ~80% when compared to the
wild type mice and by ~66% when compared to Xbp1WT Matn3V194D mice suggesting a syner-
gistic effect of the two mutations (Fig 3A). Moreover, the staining for BrdU not only showed a
decrease in the relative number of BrdU positive cells, but also a reduced intensity of staining
of these positive cells, suggesting a slower rate of DNA synthesis and an impaired cell cycle
(Fig 3B).
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Fig 2. Immunohistochemical analysis of the cartilage growth plates at 3 weeks showed no difference in matrilin-3 (brown
staining) amount or the typical extracellular distribution in the Xbp1Col2CreΔex2 tissue. The Xbp1 null growth plates showed
small areas of hypocellularity consistent with the previously reported decrease in proliferation (box). Mutant matrilin-3 was
intracellularly retained (arrowhead) and depleted from the extracellular matrix in Xbp1WT Matn3V194D cartilage. Moreover, the
columnar organisation of the proliferative one was affected and the cells adopted a more rounded morphology. The removal of
XBP1 from EDM5 cartilage (Xbp1Col2CreΔex2 Matn3V194D) resulted in a dramatically aggravated phenotype with increased
UPR is an essential component of genetic skeletal disease
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Chondrocyte apoptosis in the growth plate was not affected by the deletion of XBP1 from
cartilage as previously reported (Xbp1Col2CreΔex2 compared to Xbp1WT controls)[21]. In con-
trast, the p.V194D Matn3 mutation had a slight negative effect on the levels of apoptosis in the
hypertrophic and proliferative zones, which is consistent with previous observations [33].
However, in the Xbp1Col2CreΔex2 Matn3V194D double mutant mice there was a dramatic
increase in the relative levels of chondrocyte apoptosis in the resting, proliferative and hyper-
trophic zones (1.5, ~8 and ~8-fold respectively compared to the wild type controls; Fig 3C).
Indeed, TUNEL positive cells were found throughout the growth plates of Xbp1Col2CreΔex2
Matn3V194D mice and appeared to correlate with the enlarged cell morphology previously
noted in the histological analysis (Fig 3D).
Comparative microarray analysis confirms that the XBP1 branch of the
UPR has a role in modulating the aggregation of mutant matrilin-3 in the
chondrocytes of Matn3V194D mice
Deleting XBP1 from the chondrocytes of Xbp1WT Matn3V194D cartilage further exacerbated
the disease phenotype, indicating that the XBP1 branch of the UPR pathway had a ‘chondro-
protective’ role in proliferating chondrocytes. To further define the putative protective role of
XBP1 we performed microarray analyses on mRNA derived from wild type and mutant ani-
mals with a comparable C57BL6 genetic background. Volcano plots showing the differential
expression of genes and significant changes are shown in Fig 4A–4D and a heat map compari-
son is shown in S3 Fig.
In total 2092 genes were differentially expressed in mutant Matn3 chondrocytes (Xbp1WT
Matn3V194D vs Xbp1WT analysis) compared to 2396 in XBP1 null cartilage (Xbp1Col2CreΔex2 vs
Xbp1WT), 1316 in Xbp1Col2CreΔex2 Matn3V194D vs Xbp1Col2CreΔex2 and finally 712 in Xbp1Col2CreΔex2
Matn3V194D vs Xbp1WT Matn3V194D (S3 Fig). Overall, this indicated that both the presence of the
matrilin-3 mutation and the absence of XBP1 were strong effectors of cartilage homeostasis.
The highest number of differentially expressed genes in common (1192) was noted for the
cartilage-specific deletion of XBP1 (Xbp1Col2CreΔex2 vs Xbp1WT) and the p.V194D Matn3
mutant (Xbp1WT Matn3V194D vs Xbp1WT) comparisons, suggesting that genes downstream of
the XBP1 signalling pathway are key disease modulators in matrilin-3 related MED.
Xbp1WT Matn3V194D vs Xbp1WT analysis confirmed the findings previously reported for
this mouse line [5]. The 1494 genes downregulated in the mutant Matn3 chondrocytes
(Xbp1WT Matn3V194D vs Xbp1WT) were predominantly associated with regulation of gene
expression, cell proliferation and apoptosis. A distinct subset of downregulated genes was asso-
ciated with modulating the aggregation of mutant/misfolded proteins (Cryab, Hspa1l, Hspb8,
DNaja1). Genes associated with cartilage and bone development (such as Alpl, Col1a1,
Col10a1, Evc, Hif1a, Igf1, Igfbp5, Ibsp, Mmp14, Nog, Pthlh, Smo and Tnc) were also decreased.
In contrast, 598 genes significantly upregulated in the Matn3 mutant chondrocytes (Xbp1WT
Matn3V194D vs Xbp1WT) were predominately associated with cell proliferation, migration and
the cellular response to ER stress [5] and included genes such as Creld2, Canx, Dnajc3, Grp94,
Hyou1, Manf (Armet), Pdia3, Pdia4, Trib3 and Xbp1 (S1 Table).
intracellular retention of matrilin-3 and the appearance of abnormally enlarged cells throughout the tissue (oval). Nuclear fast
green was used as a counterstain. The zone of type X collagen (red) staining was broader in the Xbp1 Col2CreΔex2Matn3V194D
growth plates at 3 weeks, reflecting the growth plate disorganisation. Type II collagen was not affected in any of the analysed
mouse models. DAPI was used as nuclear counterstain (blue).Key: RZ–resting zone, PZ–proliferative zone, HZ–hypertrophic
zone, scale bar 100μm.
https://doi.org/10.1371/journal.pgen.1008215.g002
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A Xbp1Col2CreΔex2 vs Xbp1WT comparison confirmed the previously published involvement
of Xbp1 in bone formation [21] and modulation of the ER stress response [34]. 1114 genes
downregulated in XBP1 null cartilage (Xbp1Col2CreΔex2 vs Xbp1WT) were associated with tran-
scription regulation, apoptosis, protein ubiquitination and cell cycle regulation [21]. Several
genes involved in protein folding were also decreased including Cryab, Dnajc4, Dnajc13,
Dnajc22, Hspa4l and Hspa8. 1282 genes upregulated in Xbp1 null cartilage pertained to regula-
tion of cell migration, angiogenesis and extracellular matrix organisation as previously pub-
lished [21]. Genes for several ECM proteins including Col1a1, Col10a1 Col4a1, Col4a2,
Col18a1, Fbln5 and Ibsp were also upregulated, together with several signalling molecules such
as Fgf18, Fgf2, Notch1, Tgfb2 and Vegfc, indicating a deregulation of chondrocyte differentia-
tion in the Xbp1Col2CreΔex2 mice.
A comparative analysis of genes differentially regulated by the Matn3 mutation (Xbp1WT
Matn3V194D vs Xbp1WT) with the genes differentially regulated by Xbp1 ablation in Matn3
mutant chondrocytes (Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D) was undertaken to
explain the dramatically exacerbated disease phenotype in the Xbp1Col2CreΔex2 Matn3V194D
mice and to identify Xbp1-dependent pathways in EDM5 (Fig 4E and 4F). Interestingly, the
differentially changed genes are involved in cartilage differentiation/dedifferentiation path-
ways (“lipolysis in adipocytes”, “mineral deposition”, “TGFß signalling”, “rheumatoid arthri-
tis”) and in the UPR (“protein processing in the endoplasmic reticulum”; Fig 4F). A detailed
analysis revealed 57 genes decreased in the Matn3 mutant chondrocytes and further decreased
upon XBP1 deletion, indicating their expression is modulated downstream of XBP1. The GO
terms for these genes included “protein folding”, “phospholipid biosynthesis process” and
“nucleosome assembly” (S2 Table). The most highly and significantly represented GO term
was “protein folding” and included the chaperone molecule DNAJA4, heat shock protein
HSPA8 and crystallin alpha B (CRYAB) (S2 Table); all of which lie downstream of XBP1 sig-
nalling [34]. Moreover, the genes associated with “phospholipid biosynthesis process” included
choline kinase alpha (Chka), ethanolaminephosphotransferase 1 (Ept1) and phosphatidylser-
ine decarboxylase pseudogene 3 (Pisd-ps3), involved in the maintenance of vesicular mem-
branes and in protein folding respectively.
150 genes were upregulated in the Matn3 mutant cartilage (Xbp1WT Matn3V194D vs
Xbp1WT) and downregulated upon removal of XBP1 (Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT
Matn3V194D) indicating an ER-stress triggered XBP1-dependent response (S3 Table). The top
GO terms associated with these were “response to toxic substance”, “response to lipopolysac-
caride”, “regulation of ERK1 and ERK2 cascade” and “cell migration”. The genes changed in
the “ERK1 and ERK2 signalling pathway” and “cell migration” (Abl2, Cd44, Ccl5, Prkca,
Sema7a) are known to respond to extracellular signals and may be reflecting extracellular
changes resulting from the intracellular stress. Ltbp1, one of the major players in the TGFß sig-
nalling, was dramatically increased in Matn3 mutant cartilage (Xbp1WT Matn3V194D vs
Xbp1WT) and decreased upon Xbp1 removal, but unchanged in the XBP1 null control, indicat-
ing a stress-related response. Other interesting genes upregulated in Matn3 mutant cartilage
Fig 3. (A) 2h BrdU labelling pulse was performed to assess cell proliferation in the growth plate cartilage at 3 weeks of age. Xbp1 null cartilage showed a 16% decrease in
proliferation compared to the wild type control. The proliferation in the Xbp1WT Matn3V194D cartilage was decreased by nearly 40%. Proliferation levels in the
Xbp1Col2CreΔex2 Matn3V194D cartilage reflected the synergistic effect of the two genetic insults and was decreased by 66% (n = 3, One Way ANOVA). (B) The
incorporation of the labelling agent (purple staining) into the proliferating cells was also decreased in the Xbp1Col2CreΔex2 Matn3V194D chondrocytes indicating a slowed
down cell cycle. Nuclear Fast Green was used as counterstain. (C) TUNEL assay was performed to assess apoptosis in cartilage growth plates at 3 weeks (n = 3, One Way
ANOVA). Apoptosis was dramatically increased in all zones of the Xbp1Col2CreΔex2 Matn3V194D growth plate. (D) The apoptosis, normally occurring at the lower
hypertrophic zone in the cartilage growth plate, was also dysregulated in the Xbp1Col2CreΔex2 Matn3V194D with cells dying in the proliferative and resting zones as well.
Interestingly, the cells undergoing apoptosis correlated with the abnormally enlarged cellular morphology. Positive cells shown in green, DAPI used as nuclear
counterstain (blue). Key: RZ–resting zone, PZ–proliferative zone, HZ–hypertrophic zone, � P<0.05, �� P<0.01, ��� P<0.001, scale bar 100μm.
https://doi.org/10.1371/journal.pgen.1008215.g003
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but downregulated upon removal of Xbp1 were Mmp3, Mmp10, Adam19 and Sost, suggesting
potential changes in chondrocyte maturation and differentiation. Moreover, several genes
upregulated in mutant Matn3 cartilage and decreased upon removal of Xbp1 (Abcb1a, Creld2,
Pdia6, Dnajc3, Ero1lb, Hao1, Hyou1, Magt1, Pex11a, Sdf2l1, Ugt1a1) reflected changes in pro-
tein folding, disulphide bond formation, peroxisome activity and drug metabolism machinery
implying an Xbp1-dependent non-canonical stress pathway is activated by the accumulation
of misfolded aggregated matrilin-3. Interestingly, some of these genes were also implicated in
the pathobiology of other aggregation-related diseases such as Alzheimer’s [17, 35].
A total of 79 genes were downregulated in Matn3 mutant chondrocytes (Xbp1WT
Matn3V194D vs Xbp1WT analysis) but upregulated in Matn3 mutant chondrocytes lacking
XBP1 (Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D) and the main GO term in this
comparison was “osteoblast differentiation” (S4 Table). The genes associated with this group-
ing (Col1a1, Igf1, Igfbp5, Ibsp, Tnc) were downregulated by the presence of matrilin-3 muta-
tion on both Xbp1 backgrounds (wild type and null), indicating their downregulation in
response to aggregation stress, and upregulated by the absence of XBP1 on wild type or matri-
lin-3 mutant background thereby suggesting XBP1 regulation [21].
Only 4 genes were increased in both Xbp1WT Matn3V194D vs Xbp1WT and in Xbp1Col2CreΔex2
Matn3V194D vs Xbp1WT Matn3V194D and these were Serpina3c, Serpina3n, Ptger and a hypo-
thetical protein (2310033P09Rik).
Differential expression profiling helps separate the aggregation-dependent
and the XBP1-dependent molecular events
Expression profiling of the Matn3 mutant cartilage (Xbp1WT Matn3V194D vs Xbp1WT) com-
pared to the Matn3 mutant cartilage on the XBP1-null background (Xbp1Col2CreΔex2
Matn3V194D vs Xbp1Col2CreΔex2) was performed in order to elucidate the molecular events spe-
cifically dependent upon matrilin-3 mutation and independent of the UPR signalling down-
stream of XBP1 (Figs 5 and 6). 47 genes were upregulated (Fig 5B) and 246 genes
downregulated (Fig 6B) in the presence of the matrilin-3 mutation. The upregulated genes
clustered in “metabolic process” and “protein folding” GO terms and included Bcat2, Lpcat1,
Pnpla3 and Uap1, and Atf5, Canx, Derl3, Manf, Pdia3, Pdia4 and Pdia6 respectively. The
downregulated genes pertained to “endochondral ossification” and included Alpl, Col1a1,
Col10a1, Cyr61, Dlx5, Gabbr1, Igf1, Ibsp, Mef2c, Mmp14, Pthlh and Tnc; and “protein folding”
including Cryab, Dnaja1, Dnaja4, Hspa4l, Hspa8, Hsp90aa1, Tubb5. Interestingly, a subset of
ER-stress related genes downregulated independently of XBP1 in the presence of mutant
matrilin-3 (Cryab, Dnaja4, Hspa8 and Hsp90aa1) were further decreased in the Xbp1Col2CreΔex2
Matn3V194D vs Xbp1WT Matn3V194D analysis and decreased in the Xbp1 null cartilage
(Xbp1Col2CreΔex2 vs Xbp1WT analysis), indicating a synergistic effect of the two stressors and
potential XBP1 modulation.
62 genes were upregulated (Fig 5C) and 165 genes downregulated (Fig 6C) following the
removal of Xbp1 from chondrocytes with or without the Matn3 mutation (i.e. Xbp1Col2CreΔex2
vs Xbp1WT compared to Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D) indicating UPR-
independent XBP1 signalling. The upregulated genes largely pertained to extracellular matrix
Fig 4. (A-D) Volcano plots of differential gene expression (in black) highlighting the significantly changed genes (1.5 fold, P<0.05; in red). (E) A Venn diagram
comparing the significantly differentially expressed genes in the original EDM5 (Xbp1WT Matn3V194D vs Xbp1WT Matn3WT) model and the effect of XBP1 deletion
(Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D). (F) Pathway analysis of the Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D microarray data was performed
using the iPathwayGuide platform (Advaita Corp). Differentially expressed KEGG pathways are plotted using the P-values and the number of differentially expressed
probes.
https://doi.org/10.1371/journal.pgen.1008215.g004
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organisation and osteoblast differentiation (e.g. Col1a1, Igf1, Igfbp3, Igfbp5, Ibsp, Vegfc), which
is in agreement with previously published data [21], whereas the downregulated genes were
clustered to RNA splicing (e.g. Prpf38b, Rbm25, Rbm5, Cpsf6, Hspa8, Mbnl1, Srrm2, Tra2a)
and protein folding (Ahsa1, Pdia6).
Aggregation-specific ER-resident chaperones are differentially expressed in
chondrocytes from the MCDS and EDM5 mice, delineating a
differentiation state specific stress response
Removal of Xbp1 had a profound effect on the phenotype of EDM5 mice, which is a disease
predominantly affecting chondrocytes undergoing proliferation, but in contrast, deletion of
Xbp1 had no effect on the severity of MCDS, a disease of the hypertrophic zone of the growth
plate [31]. We therefore assessed the modulation of the UPR machinery in different zones by
comparing entire growth plate microarrays (Xbp1Col2CreΔex2 vs Xbp1WT) against a dataset gen-
erated for the hypertrophic zone only (Xbp1Col2CreΔex2(HZ) vs Xbp1WT(HZ); GEO series acces-
sion number GSE72261).
Interestingly, both the hypertrophic zone alone and the full cartilage growth plate showed
unique gene expression signatures upon removal of Xbp1 (S3 Fig). For example, whilst Pdia6
was decreased in both the hypertrophic zone and the full growth plate following XBP1 abla-
tion, the genes encoding other aggregation-specific chaperones such as Cryab, Dnaja4, Hspa1l
and Hspa8 were decreased in chondrocytes from the whole growth plate, but not in hypertro-
phic zone chondrocytes alone, suggesting differentiation-state dependent XBP1 modulation.
In contrast, ATF6 signalling appeared to be affected by the deletion of XBP1 in both the whole
growth plate and the hypertrophic zone alone. In the hypertrophic zone this resulted in an
upregulation of the more stable, but weaker activator ATF6ß, whereas the full growth plate
analysis showed an increase in ATF6ɑ and no change in ATF6ß, potentially indicating a
decrease in ATF6ß in the proliferative zone and a differentiation-state dependent modulation
of ATF6 signalling.
We then compared the microarray data generated using hypertrophic chondrocytes from
the MCDS mice [36] with the microarray data of chondrocytes from the EDM5 mice to deter-
mine the cellular response to the retention and aggregation of mutant protein (S3 Fig). 586 dif-
ferentially expressed genes were shared between the MCDS (Col10a1N617K vs. Col10a1WT) and
EDM5 (Matn3V194D vs. Matn3WT) cartilage. 136 genes were upregulated in both mice and the
main GO term for these was “ER response” and included the following genes, Atf5, Atf6,
Creld2, Derl3, Dnajc3, Hsp90b1 (Grp94), Hyou1, Manf, Pdia3, Pdia4, Trib3 and Xbp1. Of these
genes Creld2, Dnajc3 and Hyou1 appeared to be controlled by XBP1 under ER stress as sug-
gested by their downregulation in the Xbp1Col2Δex2 Matn3V194D vs. Xbp1WT Matn3V194D com-
parison. In contrast, Atf5, Derl3, Hsp90b1, Manf and Pdia4 were all upregulated or unchanged
in Xbp1Col2Δex2 Matn3V194D vs. Xbp1Col2Δex2 and in Xbp1WT Matn3V194D vs. Xbp1WT compari-
sons, indicating an XBP1-independent effect of mutant protein misfolding/aggregation. Inter-
estingly, several of these genes have previously been shown to be downstream of ATF6
signalling ([34]; Table 1). 169 genes were downregulated in both comparisons and the top GO
term for these was “skeletal development”, including genes such as Alpl, Bcan, Cebpd, Col1a1,
Crlf3, Deaf1, Foxa2, Ibsp, Kazald1, Mmp14, Nog, Smo and Sox4. Many of these represent a
Fig 5. (A) Venn diagram showing an overlap in the significantly upregulated microarray probes from the 4 analyses (Xbp1WT Matn3V194D vs Xbp1WT, Xbp1Col2CreΔex2
Matn3V194D vs Xbp1Col2CreΔex2, Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D and Xbp1Col2CreΔex2 vs Xbp1WT. (B) A graph showing the GO terms associated with
47 upregulated probes representing the XBP1 independent effect of a MATN3 mutation. (C) A graph showing the GO terms associated with 62 upregulated probes
representing the MATN3 mutation independent effect of XBP1 deletion.
https://doi.org/10.1371/journal.pgen.1008215.g005
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delay in terminal differentiation, which could explain the phenotype of short-limbed dwarfism
in both mouse models. ER stress related genes that were differentially expressed between the
two models included Ahsa1, Cryab, Hspa8, Hsp90aa1 and Hsph1, all of which were downregu-
lated in Matn3 mutant (Matn3V194D vs. Matn3WT) cartilage and upregulated in the Col10a1
Fig 6. (A) Venn diagram showing an overlap in the significantly downregulated microarray probes from the 4 analyses (Xbp1WT Matn3V194D vs Xbp1WT,
Xbp1Col2CreΔex2 Matn3V194D vs Xbp1Col2CreΔex2, Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D and Xbp1Col2CreΔex2 vs Xbp1WT. (B) A graph showing the GO terms
associated with 47 downregulated probes representing the XBP1 independent effect of a MATN3 mutation. (C) A graph showing the GO terms associated with 62
downregulated probes representing the MATN3 mutation independent effect of XBP1 deletion.
https://doi.org/10.1371/journal.pgen.1008215.g006
Table 1. A table summarising microarray data of the differential expression of representative IRE1ɑ (XBP1),
ATF6 and PERK target genes [34, 37–40] in the EDM5 and MCDS models, and in EDM5 upon removal of XBP1
(EDM5/X). n.s. = not significant.
Xbp1 target genes EDM5 EDM5/X MCDS
Abcb1a 4.57 -3.19 n.s.
Edem3 n.s. -2.28 2.64
Hao1 16.67 -2.60 n.s.
Pdia6 1.60 -1.86 4.93
Pex11a 1.62 -1.99 n.s.
Ugt1a1 1.90 -3.47 n.s.
ATF6 target genes EDM5 EDM5/X MCDS
Canx 1.86 n.s. 1.87
Derl3 25.20 n.s. 19.7
Ero1l 1.86 n.s. 8.57
PERK target genes EDM5 EDM5/X MCDS
Ddit3 -2.28 n.s. 24.25
Fads3 n.s. n.s. 3.25
Herpud1 n.s. n.s. 4.59
Hspa9 n.s. n.s. 5.28
Leprotl1 n.s. n.s. 3.48
Steap1 n.s. n.s. 12.99
Genes downstream of ATF6 and/or PERK EDM5 EDM5/X MCDS
Manf 2.13 n.s. 3.03
Pdia3 2.28 n.s. 2
Pdia4 2.52 n.s. 16
Genes downstream of Xbp1 and/or ATF6 EDM5 EDM5/X MCDS
Creld2 2.84 -2.32 7.46
Dnajc3 3.98 -1.52 3.73
Grp94 1.86 n.s. 9.85
Hyou1 3.74 -1.66 4.59
Xbp1 2.07 -1.64 2.82
Genes downstream of synergy of ATF6 and Xbp1 EDM5 EDM5/X MCDS
Derl1 n.s. n.s. 4.59
Derl2 n.s. n.s. 1.51
Edem1 n.s. n.s. 2.83
Edem2 n.s. n.s. n.s.
Sel1l n.s. n.s. 4.59
Syvn1 n.s. n.s. 3.03
Vcp n.s. n.s. 1.51
https://doi.org/10.1371/journal.pgen.1008215.t001
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mutant (Col10a1N617K vs. Col10a1WT) comparison. These were downregulated in mice
expressing mutant matrilin-3 in both the presence and absence of XBP1, but were further
downregulated upon ablation of Xbp1 indicating that they are ER-stress responsive and
XBP1-dependent. Moreover, the transcriptomic comparison of EDM5 and MCDS growth
plate chondrocytes suggested specific involvement of ATF6 and XBP1 signalling pathways in
the UPR responses in the EDM5 mouse model, and an ATF6 and PERK-specific response in
the MCDS cartilage (Table 1).
In order to further confirm the lack of PERK involvement in EDM5 pathobiology, the UPR
data obtained from the microarray analysis were verified by quantitative real-time RT-PCR
analysis of Ire1, Atf6, Perk (Fig 7A). Interestingly, the expression levels of Ire1 and Perk were
unchanged in all genotypes analysed, when compared to the wild type controls. Western blot-
ting of total cartilage homogenates was used to verify the protein levels of IRE1, ATF6 and
PERK (Fig 7B and 7C). Individual blots and loading controls are shown in S4 Fig. The results
of densitometry analysis of the Western blots corresponded to the qPCR data and showed no
difference in PERK and IRE1 protein levels across the genotypes, and an increase in ATF6 pro-
tein levels in EDM5 cartilage (1.7 fold), with a corresponding 1.4 fold increase in the amount
of the active (cleaved) ATF6, further confirming the activation of the ATF6 signalling branch
of the UPR in EDM5 tissue. ATF6 protein levels were also elevated in EDM5 cartilage lacking
XBP1 (2.5 fold) when compared to wild type controls but were not statistically different when
compared to EDM5 samples.
We also assessed the expression levels of selected downstream targets of the IRE1, ATF6
and PERK signalling branches of the UPR in mRNA isolated from primary chondrocytes
extracted from cartilage (Fig 8A). These genes included Pdia6 (downstream of Xbp1), Creld2
(regulated by Atf6 and Xbp1), Derl1 (downstream of synergistic actions of Xbp1 and Atf6),
Grp94 (downstream of Atf6), Manf (regulated by Atf6 and Perk), and Ddit3 (downstream of
Perk). Interestingly, whilst the levels of Xbp1 and Atf6 effectors were increased (Creld2
2.2-fold, Grp94 5.1 fold, Manf 1.6 fold, Pdia6 1.7 fold), the levels of Perk and of Ddit3, a pro-
apoptotic gene specifically regulated by PERK, were not changed in the EDM5 tissues, further
confirming the specific ATF6 and XBP1 involvement in EDM5 pathobiology. In addition,
genes that are regulated or co-regulated by Xbp1 (Creld2, Derl1, Pdia6) were downregulated in
EDM5 chondrocytes upon XBP1 removal, whereas genes downstream of Atf6 (Grp94, Manf)
and Perk (Ddit3) were unchanged, further confirming our hypothesis. Moreover, Western
blotting of total cartilage homogenates was used to verify the protein levels of PDIA6 (down-
stream of IRE1/XBP1), and CHOP (DDIT3) and ATF4 (both downstream of PERK), in
Xbp1WT, Xbp1WT Matn3V194D, Xbp1Col2Δex2 and Xbp1Col2Δex2 Matn3V194D cartilage (Fig 8B).
The results of densitometry analysis of the Western blots were consistent with the expression
levels seen in the mRNA analysis and showed a 2.3 fold increase in PDIA6 levels in EDM5 car-
tilage and a decrease to wild type levels upon XBP1 deletion. Moreover, the densitometry anal-
ysis further confirmed the lack of involvement of the PERK branch of the UPR in the EDM5
disease signature and showed suppression of PERK mediated signals (both ATF4 and CHOP
protein levels were decreased in EDM5 cartilage, 0.8 and 0.4 fold, respectively). Changes in the
expression levels of ATF6/XBP1 regulated chaperone CRELD2, aggregation-related chaperone
protein PDIA6 and proliferation regulator p58IPK (DNAJC3) were further verified in wild type
and mutant cartilage growth plates by immunohistochemistry (Fig 8C). All three of these effec-
tors were upregulated in the p.V194D Matn3 mutant cartilage and decreased upon deletion of
XBP1, indicating XBP1-dependence of EDM5 UPR signalling. Interestingly, p58IPK has been
shown to dampen PERK signalling and attenuate eIF2ɑ phosphorylation [40, 41]. Moreover, it
has been shown that PERK can modulate Xbp1 expression and splicing in response to mutant
protein aggregation [42, 43]. This effect of PERK signal on IRE1ɑ activity and splicing of Xbp1
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can be evidenced by a decreased ratio of alternatively spliced Xbp1 (Xbp1s) to unspliced Xbp1
(Xbp1u) in the EDM5 compared to the MCDS chondrocytes (S3 Fig).
Discussion
The IRE1ɑ/XBP1 signalling branch is the most conserved branch of the UPR, essential in cel-
lular response to the accumulation of misfolded proteins by regulating chaperone protein
expression and ER-associated protein degradation (ERAD). Most likely due to the high protein
secretory burden of chondrocytes and osteoblasts and the need for robust ER machinery dur-
ing long bone growth [44, 45], this pathway is also important for skeletal development and was
shown to regulate osteoblast differentiation in vitro [44] and chondrocyte proliferation and
bone mineralisation in vivo [21]. XBP1 is the main effector of the pathway and Xbp1 gene is
non-conventionally spliced by autophosphorylated IRE1ɑ following its dissociation from the
main UPR sensor BiP. The spliced form (XBP1s) then translocates to the nucleus to act as a
transcription factor and activates genes encoding chaperones and ERAD components [7]. The
unspliced form (XBP1u) has a shorter half-life and can shuttle between the nucleus and the
cytoplasm where it can aid in proteasomal degradation of XBP1s protein and/or the active
form of ATF6 thereby acting as a regulator of UPR signalling [46, 47].
Xbp1s mRNA has been identified in the ‘disease signature’ of many conditions resulting
from the ER retention of misfolded mutant protein [34] and in particular several diseases char-
acterised by the formation of insoluble intracellular aggregates such as type II diabetes [20],
Alzheimer’s disease [17, 35], Huntington’s disease [18, 19], metaphyseal chondrodysplasia
type Schmidt (MCDS) [6, 36] and matrilin-3 related multiple epiphyseal dysplasia (EDM5) [5,
33], suggesting XBP1-dependent modulation of ER stress in these conditions. More specifi-
cally, it has previously been shown that MCDS and EDM5 share a common disease signature
consistent with a classical UPR and defined by an upregulation of ATF6, alternative splicing of
Xbp1 and an increase in Canx, Creld2, Derl3, Dnajc3, Hyou1, Manf, Pdia3, Pdia4, Pdia6 and
Xbp1 gene expression [32]. It was therefore surprising that deletion of XBP1 in chondrocytes
of a MCDS mouse model had no effect on the severity of the skeletal phenotype [31]. In con-
trast, deleting XBP1 from chondrocytes in the mouse model of EDM5 resulted in a dramatic
increase in disease severity with significantly shorter limbs, deformed ribcages, severely dis-
rupted cartilage growth plates and increased retention of mutant matrilin-3, suggesting an
important role for XBP1 in response to abnormal protein aggregation in proliferating chon-
drocytes. Chaperone proteins involved in the processing of insoluble intracellular aggregates
and already decreased in EDM5 chondrocytes (such as CRYAB, DNAJA1, DNAJA4, HSP1L
and HSPA8), were further decreased following the deletion of XBP1. Interestingly, several of
these were differentially expressed between the MCDS and EDM5 mice, indicating that the dif-
ferentiation state of certain cells can influence their response to aggregation of mutant mis-
folded protein [36]. Moreover, several genes pertaining to proteasomal degradation (Derl1,
Derl2, Edem1, Edem3) and autophagy (Atg2b, Atg4b, Atg5, Atg10, Atg12, Atg13) were upregu-
lated in MCDS chondrocytes, but not EDM5 chondrocytes, indicating that despite toxic pro-
tein aggregation MCDS chondrocytes were able to upregulate crucial components of the
degradation machinery. Interestingly, a recent study showed that the proteasomal and
Fig 7. (A) Real time RT-qPCR data verifying expression levels of Atf6, Ire1 and Perk using mRNA extracted from 5 day old chondrocytes (n = 3, Student t-test). No
detectable changes in Perk expression confirm lack of involvement of the PERK signalling pathway in EDM5 pathobiology. (B) Densitometry measurement of 3
biological replicates of Western blotting for ATF6, IRE1 and PERK, showing no difference in IRE1 and PERK protein levels in EDM5 cartilage with or without XBP1.
Interestingly, the amount of total and active (cleaved) ATF6 was dramatically increased in EDM5 cartilage compared to wild type controls and upon further XBP1
deletion. (C) Representative Western blotting images. Key: � P<0.05, �� P<0.01, ��� P<0.001, scale bar 100μm.
https://doi.org/10.1371/journal.pgen.1008215.g007
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autophagy inducer carbamazepine can enhance these responses and reduce the intracellular
retention of mutant collagen X and restore long bone growth in MCDS mice [48].
The differences in the response to prolonged/chronic ER stress between proliferative and
hypertrophic chondrocytes might stem from differentiation-specific variances in the basal lev-
els of the three canonical ER stress pathways in the different zones of the cartilage growth
plate. In physiological conditions the levels of ATF6ɑ and PERK are increased in hypertrophic
chondrocytes compared to proliferative chondrocytes, whilst IRE1ɑ signalling appears more
important in the proliferative zone of the growth plate (Fig 9A, [36, 49, 50]). It has been shown
that the deletion of the ɑ or the ß isoform of ATF6 differentially affects the cartilage growth
plate both in physiological conditions and following disease-associated ER stress, further con-
firming a modulation of the UPR through the differentiation state of a chondrocyte [51]. Inter-
estingly, the levels of XBP1 are also increased in chondrocytes of the normal hypertrophic
zone, potentially due to upregulated ATF6 signalling associated with hypertrophy [52, 53]. It is
therefore not surprising that upon the induction of ER stress, ATF6ɑ and PERK were further
upregulated in the hypertrophic MCDS chondrocytes. Xbp1 expression was induced in the
hypertrophic cells of MCDS mice and Xbp1 was alternatively spliced, although the levels of
IRE1ɑ did not increase (Fig 9A and 9B, [36]). Expression of genes downstream of ATF6
(including Xbp1 [54]) and PERK (Ddit3, Cebpb), as well as the expression of ERAD genes
requiring the synergy of XBP1s and ATF6 signalling were upregulated in Col10a1N617K mice
(Table 1, [55]). However, this was not sufficient in itself to trigger the ERAD pathway as evi-
denced by the increased intracellular retention of type X collagen in MCDS chondrocytes and
the observation that MCDS mice lacking Xbp1 showed no increase in disease severity [31].
In contrast, ER/cell stress induced by the aggregation of misfolded mutant matrilin-3 pro-
tein in proliferative chondrocytes of EDM5 mice resulted in upregulation of Atf6a, and upre-
gulation of protein levels of ATF6 and its downstream effectors (GRP94, MANF). Expression
level of Ern1 (gene encoding IRE1ɑ) was not changed in EDM5 cartilage; however, the IRE1ɑ
activity was enhanced, as evidenced by increased Xbp1 splicing and upregulation of XBP1
effectors (CRELD2, PDIA6). Interestingly, the levels of PERK and its downstream targets
(ATF4, DDIT3) were not increased in EDM5 cartilage. ATF6 and XBP1 can form heterodi-
mers and several UPR effectors can be modulated by either XBP1 or ATF6 or only by the
actions of both [37, 55]. Interestingly, the expression of Dnajc3, which is downstream of XBP1
and ATF6, was increased in EDM5 chondrocytes and potentially further dampened PERK sig-
nalling [40, 41], as evidenced by a decrease in protein levels of PERK downstream effectors,
ATF4 and DDIT3 in EDM5 cartilage. We therefore hypothesise that the UPR response in
chondrocytes of the proliferative zone is primarily due to interplay between ATF6 and IRE1ɑ
signalling and is not influenced by PERK. Therefore, the interplay between the XBP1 and
ATF6 signalling is crucial for the pathobiology of aggregation-related diseases and that the
modulation of the XBP1 pathway may present a promising therapeutic target.
The potential role of PERK modulation of Xbp1 expression and Xbp1 splicing in response
to mutant protein aggregation in hypertrophic cells is an interesting aspect that requires fur-
ther investigation [42, 43]. The effect of PERK signalling on IRE1ɑ activity and splicing of
Fig 8. (A) Real time RT-qPCR of genes downstream of XBP1, XBP1/ATF6 and PERK signalling. Creld2, Derl1 and Pdia6 (downstream of XBP1) follow an XBP1
dependent pattern of expression, and are upregulated in EDM5 cartilage and decreased upon deletion of XBP1. Grp94 and Manf (downstream of ATF6 and/or XBP1)
appear to be ATF6-dependent in EDM5 cartilage and are not affected by lack of XBP1 in Xbp1Col2CreΔex2 Matn3V194D tissue. The mRNA levels of Ddit3 (Chop), a
downstream effector of PERK, are not changed in any of the mouse lines analysed. (B) Densitometry measurement of 3 independent biological replicates of Western
blotting for PDIA6 (downstream of XBP1), and ATF4 and DDIT3 (CHOP) (both downstream of PERK), showing a decrease in PERK effector levels in EDM5 cartilage.
(C) Immunohistochemical staining of 3 week old cartilage growth plates showing a decrease in p58IPK, PDIA6 and CRELD2 staining (red) upon XBP1 deletion in the
EDM5 cartilage. DAPI (blue) was used as a counterstain (blue). Key: � P<0.05, �� P<0.01, scale bar 100μm.
https://doi.org/10.1371/journal.pgen.1008215.g008
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Fig 9. (A) Schematic explaining the basal levels of expression of the UPR sensors in the different zones of the cartilage growth plate and their differential
expression upon the protein aggregation insult. (B) A schematic presenting the cross-talk of the UPR signalling branches upon misfolded protein aggregation
UPR is an essential component of genetic skeletal disease
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008215 July 1, 2019 21 / 30
Xbp1 can be evidenced by a decreased ratio of Xbp1s:Xbp1u in the EDM5 compared to the
MCDS chondrocytes. It is therefore interesting to speculate that inducing the upregulation of
PERK signalling in EDM5 chondrocytes may lead to a preferential upregulation of XBP1-de-
pendent ERAD or autophagy [43]. The upregulation of many ERAD and autophagy compo-
nents in the MCDS cartilage, and the ability of carbamazepine to induce degradation of
mutant collagen X, may also be a result of the hypertrophic chondrocytes being “ERAD
primed” through their differentiation process (Fig 9B, [36, 56, 57]).
Several of the XBP1-dependent genes identified in our EDM5 study play a role in an intra-
cellular pathway for the removal of xenobiotics and lipophilic substances. In particular Abcb1,
Ugta1a1 and Hao1 were upregulated in the EDM5 chondrocytes and downregulated upon
removal of Xbp1, indicating an alternative XBP1-dependent pathway triggered by the aggrega-
tion of mutant protein. STRING visualisation of the UPR genes differentially expressed in
EDM5 cartilage and modulated by XBP1 reveals a potential experimentally supported “aggre-
gosome” (Fig 9C). Interestingly, this disease signature is similar to Alzheimer’s disease (AD)
models with intracellular retention of amyloid-like deposits. Specifically, Creld2, Dnajc3,
Manf, Pdia3 and Pdia6 are upregulated both in EDM5 and in AD, and Cryab, Dnaja4 and
Hsph1 are downregulated in both conditions whilst ERAD components are not affected [58].
CRYAB and HSPH1 are both chaperone proteins that prevent aggregation of mutant proteins
and defects in CRYAB have been associated with Huntington’s disease and Alzheimer’s dis-
ease, where its levels decrease in age-dependent manner [59–61]. It is therefore interesting to
speculate that these two chaperones could represent potential therapeutic targets for EDM5
and other protein aggregation related diseases. In fact, overexpression of CRYAB in a mouse
model of Huntington’s disease was shown to be neuroprotective and reduced the size of aggre-
gate inclusions in the affected brains [62].
Finally, a polymorphism in the Xbp1 promoter is one of the risk factors for Alzheimer’s dis-
ease [17] and the pathobiology of protein aggregation conditions such as Alzheimer’s and
Huntington’s disease can be regulated via a modulation of the IRE1ɑ-XBP1 branch of the UPR
[18, 19, 35]. Our data suggests that the pathobiology of EDM5 is governed by the tight regula-
tion between the IRE1ɑ and ATF6 signalling and a balance between the spliced and unspliced
forms of Xbp1. It is therefore interesting to speculate that modifying the XBP1 signalling path-
way via chemical or genetic intervention might present a therapeutic avenue for a broader
range of protein aggregation diseases, leading to an increase in ERAD or autophagy, or an
increased sensitivity to degradation-inducing therapies such as carbamazepine treatment. Sev-
eral studies in normal cells, cancer and disease models have previously identified chemicals
that activate or block the RNAse and/or kinase activity of IRE1ɑ and modulate the Xbp1s:
Xbp1u ratio as potential therapeutic modifiers of the IRE1ɑ/XBP1 signalling pathway [63–66].
This study further confirms the importance of this pathway in degradation of insoluble intra-
cellular aggregates and offers a novel therapeutic avenue that could be applicable to a broader
range of aggregation conditions.
Materials and methods
Generation of mouse lines
Xbp1WT Matn3V194D mice [33] were crossed with Xbp1Col2CreΔex2 mice [21] in which Xbp1
mRNA is inactivated by the Col2a1 promoter-driven Cre recombinase-mediated deletion of
in the proliferative (EDM5) and hypertrophic (MCDS) zones. (C) STRING visualisation of XBP1 modulated genes differentially expressed in the 5 day old
EDM5 cartilage compared to the wild type control showing the postulated “aggregosome”.
https://doi.org/10.1371/journal.pgen.1008215.g009
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exon 2 to generate the compound mutant mouse line, Xbp1Col2CreΔex2 Matn3V194D. All the
mice were generated on the C57BL6/J background to control for the background effects. Gen-
otyping was performed as previously described and RT-PCR and sequencing were performed
on cartilage RNA to confirm deletion of Xbp1 exon 2 in mutant chondrocytes.
Ethics statement
All experiments were approved by the University of Manchester Animal Ethical Review Group
and performed in compliance with the Scientific Procedures Act of 1986 and the relevant
Home Office (under PPL 40/2884 and PPL60/04525) and Institutional regulations governing
animal breeding and handling.
Bone measurements
Mice of different genotypes (>5 per age per genotype) were sacrificed at 3, 6 and 9 weeks of
age and X-rayed using Faxitron MX-20 X-ray machine. The bones were measured using Fiji
ImageJ platform (National Institutes of Health, Bethesda, Maryland, USA; [67]) and one way
ANOVA and Student t-test were applied for statistical analysis.
Histology and immunohistochemistry
Mice were sacrificed at 3 weeks of age, hindlimbs were dissected and fixed in either PFA (his-
tology) or 95% ethanol 5% acetic acid (immunohistochemistry) for 48h in 4˚C. The limbs were
then decalcified in 20% EDTA pH 7.4 over 2 weeks, wax embedded and cut into 6μm sections.
Haematoxylin/eosin (H&E) staining was used to visualise the general morphology of the tissue,
using the automated Thermo Shandon stainer.
Immunohistochemistry and BrdU labelling (measurement of cell proliferation) were per-
formed as described previously [30]. Primary antibodies were used at a dilution of 1:500 (ER
stress: BiP, GRP94 and CRELD2 from R&D Systems; PDIA6 from Abcam, p58IPK from Santa
Cruz Biotechnology; ECM: type I collagen, type II collagen from Abcam; matrilin-3 from R&D
Systems; type X collagen [68]). BrdU labelled cells were counted using the Watershed algo-
rithm on the Fiji ImageJ platform (National Institutes of Health, Bethesda, Maryland, USA;
[67]) and presented as percentage of total cells in the proliferative zone and On-Way ANOVA
was used for statistical analysis of data.
TUNEL assay
TUNEL assay was performed on PFA fixed sections of 3 week old limbs using the Promega
Dead-End Fluorimetric Kit as previously [33]. The samples were unmasked using citric buffer
boil instead of proteinase K unmasking, which can generate false positives [69]. Positive cells
labelled with FITC were counted using the Watershed algorithm on Fiji ImageJ platform
(National Institutes of Health, Bethesda, Maryland, USA; [67]) and presented as percentage of
all (DAPI stained) cells in selected zones of the growth plate. One-Way ANOVA was used for
statistical analysis of the data.
Isolation of costal chondrocytes
Costal chondrocytes were isolated from pooled litters of 5 day-old mice as described previously
[5]. For RNA analysis, the cell pellet was resuspended in TRIzol reagent (Invitrogen), flash fro-
zen and stored at -80˚C until RNA extraction. For protein analysis, chondrocyte aliquots of 1.5
x 105 cells were re-suspended in SDS loading buffer and frozen at -20˚C until analysis.
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Microarray analysis of rib chondrocytes
RNA was extracted from isolated chondrocytes using Trizol reagent, according to the manu-
facturer’s protocol (Life Technologies). Wild type and mutant RNA was pooled from 3 sepa-
rate extractions, and the submitted to the Genomic Technologies Core Facility, University of
Manchester for analysis. RNA integrity was analysed on the 2100 Bioanalyser (Agilent Tech-
nologies). A GeneChip 3’ expression assay (Mouse430_2 Affymetrix) was used to analyse gene
expression. Quality control checks for control hybridizations were performed using Microar-
ray Suite 5. PPLR is an R package that detects differential gene expression by including probe-
level measurement error and calculating the probability of positive log-ratio (PPLR). The dif-
ferentially expressed (over 1.5 fold change, PPLR of 1.0 and 0.0) genes were subjected to func-
tional annotation analysis using Database for Annotation, Visualisation and Integrated
Discovery (DAVID) software [70, 71]. This analysis assigned significantly up/downregulated
genes into structural, compartmental and functional-related clusters (GOTERMS). Pathway
analysis of the significantly changed genes in the Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT
Matn3V194D microarray data was performed using the iPathwayGuide platform (Advaita
Corp; http://www.advaitabio.com/ipathwayguide). This software analysis tool implements the
Impact Analysis approach that takes into consideration the direction and type of all signals on
a pathway [72].
Data availability
The full datasets are available from the NCBI Gene Expression Omnibus (GEO), accession
number GSE120308 (http://www.ncbi.nlm.nih.gov/geo/).
Quantitative RT-PCR analysis of rib chondrocytes
Microarray data were verified by quantitative real time PCR. Briefly, First-strand cDNA was
synthesised using random hexamer primers and the GoScript Reverse Transcriptase System
(Promega), and qPCR was performed using the SYBR green PCR protocol (Applied Biosys-
tems) on the Chromo4 real-time PCR system (Bio-Rad). Primer sequences are presented in S5
Table. Each experiment included ‘no template’ controls, was run in duplicate and had an 18S
RNA control. Each independent experiment was repeated three times, and the results were
analysed by independent-samples t-test.
Western blotting of cartilage homogenates
Tissue homogenates were prepared by homogenising liquid nitrogen frozen 3 week old femo-
ral head tissue in PBS using a microdismembranator for 2 min at 2,000rpm (Sartorius Ltd).
Samples (30μg of total protein) were denatured at 95˚C for 5 min in SDS-PAGE loading buffer
containing 100 mM dithiotreitol (DTT. Proteins were separated by SDS-PAGE using Novex
NuPAGE 4–12% Bis Tris precast gels in MES running buffer (Fisher Scientific) at 200 V for 60
minutes and electroblotted onto a nitrocellulose membrane for 1 hour at 30 V. Gel loading
was assessed using REVERT Total Protein Stain (LI-COR Biosciences) according to manufac-
turer’s instructions. Membranes were blocked in 3% Milk in PBS-T, incubated with primary
antibodies (1:100, ATF4 118155 (Cell Signalling Technology Inc.), ATF6 70B1413.1 (Enzo Life
Sciences Inc.), DDIT3 ab11419, IRE1 ab37073, PDIA6 ab154820 (Abcam), PERK C33E10
(Cell Signalling Technology Inc.)) for 1 hour at room temperature, and probed with the appro-
priate LI-COR IRDye secondary antibody at a concentration of 1:5,000 for 1 hour. Blots were
imaged on the LI-COR Odyssey CLx Imaging System. Densitometry quantification was per-
formed using LI-COR proprietary software and verified by ImageJ. The densitometry data was
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normalised to the total protein stain to account for protein loading. The analysis was under-
taken independently by two different researchers, the data was then normalised to wild type
protein levels and statistically analysed
Supporting information
S1 Fig. X rays of one year old Xbp1WT Matn3V194D and Xbp1Col2CreΔex2 Matn3V194D mice
showing a striking limb deformity and rotation, potentially due to the pronounced hip
dysplasia as well as the constricted bell shaped ribcage characteristic of the Xbp1Col2CreΔex2
Matn3V194D line.
(TIF)
S2 Fig. Fluorescence imaging of Congo Red staining of mouse growth plates at 3 weeks of
age showing potential amyloid-like deposits in the Xbp1WT Matn3V194D and Xbp1Col2Cre-
Δex2 Matn3V194D cartilage but not rdw cartilage (positive control). Scale bar 100μm.
(TIF)
S3 Fig. (A) A heat map generated for top 200 upregulated (in red) and downregulated (in
blue) probes in the Matn3V194D vs Matn3WT (EDM5) analysis showing a high percentage of
XBP1-dependent genes (upregulated in the EDM5, downregulated in Xbp1 null cartilage and
in EDM5 lacking Xbp1). (B) Venn diagram analysis showing a comparison of all differentially
expressed genes in the compared mouse models. (C) Venn diagram showing differential gene
expression in the hypertrophic zone of Xbp1Col2CreΔex2 vs Xbp1WT cartilage compared to the
expression profile of the entire growth plate. (D) Venn diagram comparison of the differential
gene expression between the MCD and EDM5 mouse models. (E) RT-PCR quantification of
the relative levels of Xbp1u:Xbp1s in 5 day old chondrocytes showing higher availability of the
Xbp1s in the MCDS mouse model compared to the EDM5 mouse (n = 3, Student t-test).
(TIF)
S4 Fig. (A) Total protein stain showing protein loading and individual Western blotting for
ATF6, IRE1 and PERK on 3 independent biological replicates of whole femoral head cartilage
homogenates at 3 weeks of age. B) Total protein stain showing protein loading and individual
Western blotting for ATF4, DDIT3, and PDIA6 on 3 independent biological replicates of
whole femoral cartilage homogenates at 3 weeks of age. Key: uATF6 –uncleaved ATF6, cATF6
–cleaved (active) ATF6 protein.
(TIF)
S1 Table. Significantly upregulated cell proliferation, migration and cellular response to
ER stress genes in the Xbp1WT Matn3V194D vs Xbp1WT microarray comparison.
(DOCX)
S2 Table. List of 57 genes (75 probes) significantly downregulated in the Xbp1WT
Matn3V194D vs Xbp1WT comparison and further downregulated in the Xbp1Col2CreΔex2
Matn3V194D vs Xbp1WT Matn3V194D comparison.
(DOCX)
S3 Table. 150 genes significantly upregulated in the Xbp1WT Matn3V194D vs Xbp1WT analy-
sis and downregulated upon removal of Xbp1 (Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT
Matn3V194D).
(DOCX)
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S4 Table. 79 genes (97 probes) downregulated in Xbp1WT Matn3V194D vs Xbp1WT analysis
and upregulated in Xbp1Col2CreΔex2 Matn3V194D vs Xbp1WT Matn3V194D dataset.
(DOCX)
S5 Table. Quantitative RT-PCR primer sequences.
(DOCX)
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